TC Biopharm (TCBP) Short Interest Ratio & Short Volume → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free TCBP Stock Alerts $1.23 -0.22 (-15.17%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media TC Biopharm Short Interest DataCurrent Short Volume237,600 sharesPrevious Short Volume204,500 sharesChange Vs. Previous Month+16.19%Dollar Volume Sold Short$311,256.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares677,000 sharesPercentage of Shares Shorted35.10%Today's Trading Volume6,477,602 sharesAverage Trading Volume3,918,390 sharesToday's Volume Vs. Average165% Short Selling TC Biopharm ? Sign up to receive the latest short interest report for TC Biopharm and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTCBP Short Interest Over TimeTCBP Days to Cover Over TimeTCBP Percentage of Float Shorted Over Time Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide TC Biopharm Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024237,600 shares $311,256.00 +16.2%N/A0.1 $1.31 3/31/2024204,500 shares $267,895.00 -68.0%N/A0 $1.31 3/15/2024638,700 shares $1.07 million +224.2%N/A0.2 $1.68 2/29/2024197,000 shares $250,190.00 -5.1%N/A0.1 $1.27 2/15/2024207,500 shares $213,725.00 +111.7%N/A0.3 $1.03 1/31/202498,000 shares $106,820.00 +84.6%N/A0.1 $1.09 Get the Latest News and Ratings for TCBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. 1/15/202453,100 shares $135,405.00 +127.9%N/A0.4 $2.55 12/31/202323,300 shares $73,861.00 -45.7%N/A0.2 $3.17 12/15/202342,900 shares $110,682.00 -88.2%N/A0.6 $2.58 11/30/2023364,400 shares $134,062.76 +1,312.4%N/A0.5 $0.37 11/15/202325,800 shares $13,274.10 -84.3%N/A0 $0.51 10/31/2023164,000 shares $70,520.00 -11.4%N/A0.5 $0.43 10/15/2023185,000 shares $68,746.00 +2,334.2%N/A0.5 $0.37 9/30/20237,600 shares $3,268.00 -84.9%N/A0 $0.43 9/15/202350,400 shares $23,698.08 +45.2%N/A0.1 $0.47 8/31/202334,700 shares $19,432.00 -16.2%N/A0.1 $0.56 8/15/202341,400 shares $22,219.38 -52.9%N/A0.1 $0.54 7/31/202387,900 shares $54,498.00 -53.3%N/A0.1 $0.62 7/15/2023188,100 shares $96,582.95 -17.1%N/A0.4 $0.51 6/30/2023226,900 shares $122,979.80 -26.4%N/A0.4 $0.54 6/15/2023308,100 shares $188,526.39 +581.6%N/A1 $0.61 5/31/202345,200 shares $36,734.04 -6.8%N/A0.2 $0.81 5/15/202348,500 shares $36,326.50 -62.3%N/A0.2 $0.75 4/30/2023128,500 shares $142,635.00 +114.9%N/A0.4 $1.11 4/15/202359,800 shares $83,122.00 -27.1%N/A0.1 $1.39 3/31/202382,000 shares $131,200.00 +821.4%N/A0.1 $1.60 3/15/20238,900 shares $32,841.00 -88.0%N/A0 $3.69 2/28/202374,100 shares $312,702.00 +96.6%N/A0.1 $4.22 2/15/202337,700 shares $262,015.00 -44.5%N/A0 $6.95 1/31/202367,900 shares $347,648.00 -42.7%N/A0.1 $5.12 1/15/2023118,400 shares $530,432.00 +1,096.0%N/A0.2 $4.48 12/30/20229,900 shares $38,115.00 +98.0%N/A0.2 $3.85 12/15/20225,000 shares $21,150.00 -15.3%N/A0.3 $4.23 11/30/20225,900 shares $27,789.00 +110.7%N/A0.4 $4.71 11/15/20222,800 shares $23,800.00 -98.1%N/A0.2 $8.50 10/31/2022148,500 shares $25,987.50 +89.9%N/A0.7 $0.18 10/15/202278,200 shares $17,243.10 -64.1%N/A0.2 $0.22 9/30/2022217,600 shares $61,036.80 -8.2%N/A0.6 $0.28 9/15/2022236,900 shares $77,016.19 +51.7%N/A0.6 $0.33 8/31/2022156,200 shares $51,217.98 -20.6%N/A0.3 $0.33The Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest TCBP Short Interest - Frequently Asked Questions What is TC Biopharm's current short interest? Short interest is the volume of TC Biopharm shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 237,600 shares of TCBP short. Learn More on TC Biopharm's current short interest. Is TC Biopharm's short interest increasing or decreasing? TC Biopharm saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 237,600 shares, an increase of 16.2% from the previous total of 204,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does TC Biopharm's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to TC Biopharm: Acorda Therapeutics, Inc. (0.66%), Scinai Immunotherapeutics Ltd. (1.20%), Windtree Therapeutics, Inc. (0.51%), Avalon GloboCare Corp. (2.84%), SciSparc Ltd. (21.38%), Akanda Corp. (10.22%), Evelo Biosciences, Inc. (2.11%), Bone Biologics Co. (2.56%), Comera Life Sciences Holdings, Inc. (2.38%), Sintx Technologies, Inc. (2.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short TC Biopharm stock? Short selling TCBP is an investing strategy that aims to generate trading profit from TC Biopharm as its price is falling. TCBP shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TC Biopharm? A short squeeze for TC Biopharm occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCBP, which in turn drives the price of the stock up even further. How often is TC Biopharm's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCBP, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Acorda Therapeutics Short Interest Scinai Immunotherapeutics Short Interest Windtree Therapeutics Short Interest Avalon GloboCare Short Interest SciSparc Short Interest Akanda Short Interest Evelo Biosciences Short Interest Bone Biologics Short Interest Comera Life Sciences Short Interest Sintx Technologies Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCBP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyAI “wealth window” is closing June 25thParadigm Press